• OPEN AN ACCOUNT
Indian Indices
Sensex
84,929.36 447.55
( 0.53%)
Global Indices
Nasdaq
47,984.72 77.74
(0.16%)
Dow Jones
6,795.86 53.43
(0.79%)
Hang Seng
49,620.18 618.68
(1.26%)
Nikkei 225
9,823.75 49.43
(0.51%)
Forex
USD-INR
90.47 -0.43
(-0.47%)
EUR-INR
106.15 -0.72
(-0.68%)
GBP-INR
120.98 -0.85
(-0.70%)
JPY-INR
0.58 0.00
(-0.85%)

EQUITY - MARKET SCREENER

Max Healthcare Institute Ltd
Industry :  Healthcare
BSE Code
ISIN Demat
Book Value()
543220
INE027H01010
87.3372431
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
MAXHEALTH
147.09
102019.19
EPS(TTM)
Face Value()
Div & Yield %
7.13
10
0.14
 

Ram Ratna Wires receives approval under RIPS-2024 for its Bhiwadi plant
Nov 07,2025

Ram Ratna Wires announced that its Bhiwadi plant has been approved under the Rajasthan Investment Promotion Scheme (RIPS-2024). This approval entitles the company to receive Turnover Linked Incentive of 1.32% (in % of EFCI), along with Electricity Duty Exemption for 7 years and 25% Stamp Duty Reimbursement.

The Bhiwadi facility is expected to become a major growth driver for the company, strengthening Ram Ratna Wires' manufacturing capabilities and enabling us to serve high-demand markets more efficiently. With an approved Eligible Fixed Capital Investment (EFCI) of Rs 186.77 crore under RIPS-2024, the plant will benefit from fiscal incentives that enhance operational efficiency and cost competitiveness, contributing to profitability and reinforcing our leadership position in the industry.